Position in LXEO
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$149,923
+$50,848 QoQ
Shares Held
26,119
+75.0% QoQ
Ownership
0.033%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2025
3 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LXEO Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026AXQ CAPITAL, LP holds $39,371,003 across 105 Biotechnology names. LXEO ranks #75 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ROIV |
Roivant Sciences Ltd.
|
132,467 | $3,669,335 | |
| 2 | RVMD |
Revolution Medicines, Inc.
|
22,946 | $2,231,498 | |
| 3 | SRPT |
Sarepta Therapeutics, Inc.
|
98,212 | $2,137,093 | |
| 4 | RARE |
Ultragenyx Pharmaceutical Inc.
|
96,177 | $2,014,908 | |
| 5 | EXEL |
Exelixis, Inc.
|
40,931 | $1,755,530 | |
| 6 | TECH |
BIO-TECHNE Corp
|
31,978 | $1,671,170 | |
| 7 | RPRX |
Royalty Pharma plc
|
23,726 | $1,138,136 | |
| 8 | VKTX |
Viking Therapeutics, Inc.
|
34,641 | $1,127,218 |
All Filings in LXEO
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $149,923 | 26,119 | Shares | Sole | 2026-05-13 | |
| 2025-09-30 | $99,075 | 14,921 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $50,149 | 12,475 | Shares | Sole | 2025-08-12 | |
| No filing history on record for this holder in this stock. | ||||||